Skip to content
10-K

Annual Report

REATA PHARMACEUTICALS INC

0000950170-23-004236

← back to feed
Filed
Feb 24, 2023 12:00 AM ET
Period of report
—

On SEC.gov

Filing index ↗

Financials in this filing

Metric Period Value
Shares Diluted FY 2022 · Dec 31, 2022 36.52M sh
Shares Diluted FY 2022 · Dec 31, 2021 36.32M sh
Shares Diluted FY 2022 · Dec 31, 2020 33.71M sh
Capex FY 2022 · Dec 31, 2022 $3.27M
Capex FY 2022 · Dec 31, 2021 $1.33M
Capex FY 2022 · Dec 31, 2020 $927K
Operating Cash Flow FY 2022 · Dec 31, 2022 −$204.27M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$235.7M
Operating Cash Flow FY 2022 · Dec 31, 2020 −$322.34M
Cash And Equivalents FY 2022 · Dec 31, 2022 $42.31M
Cash And Equivalents FY 2022 · Dec 31, 2021 $590.26M
Stockholders Equity FY 2022 · Dec 31, 2022 −$65.7M
Stockholders Equity FY 2022 · Dec 31, 2021 $185.99M
Stockholders Equity FY 2022 · Dec 31, 2020 $417.43M
Stockholders Equity FY 2022 · Dec 31, 2019 $256.86M
Current Liabilities FY 2022 · Dec 31, 2022 $58.96M
Current Liabilities FY 2022 · Dec 31, 2021 $53.99M
Current Assets FY 2022 · Dec 31, 2022 $397.77M
Current Assets FY 2022 · Dec 31, 2021 $596.48M
Total Assets FY 2022 · Dec 31, 2022 $514.49M
Total Assets FY 2022 · Dec 31, 2021 $735.02M
Eps Diluted FY 2022 · Dec 31, 2022 −$8.54
Eps Diluted FY 2022 · Dec 31, 2021 −$8.19
Eps Diluted FY 2022 · Dec 31, 2020 −$7.35
Eps Basic FY 2022 · Dec 31, 2022 −$8.54
Eps Basic FY 2022 · Dec 31, 2021 −$8.19
Eps Basic FY 2022 · Dec 31, 2020 −$7.35
Rd Expense FY 2022 · Dec 31, 2022 $169.84M
Rd Expense FY 2022 · Dec 31, 2021 $155.99M
Rd Expense FY 2022 · Dec 31, 2020 $159.08M
Net Income FY 2022 · Dec 31, 2022 −$311.9M
Net Income FY 2022 · Dec 31, 2021 −$297.39M
Net Income FY 2022 · Dec 31, 2020 −$247.75M
Revenue FY 2022 · Dec 31, 2022 $2.22M
Revenue FY 2022 · Dec 31, 2021 $11.49M
Revenue FY 2022 · Dec 31, 2020 $9.02M